Purespring Therapeutics presents new preclinical data on novel gene therapy for IgA Nephropathy at ASN Kidney Week 2024
October 28, 2024 07:00 ET
|
Purespring Therapeutics
Results from the study underpin the potential of Purespring’s lead AAV gene therapy programme, PS-002, as an important novel modality to treat IgAN Data support progression towards a Phase I/II...
Purespring Therapeutics raises £80/$105 million in a Series B financing to transform the treatment of kidney diseases
October 09, 2024 07:00 ET
|
Purespring Therapeutics
Purespring Therapeutics raises £80/$105 million in a Series B financing to transform the treatment of kidney diseases Oversubscribed financing led by Sofinnova Partners in collaboration with Gilde...
Purespring Therapeutics raises £80/$105 million in a Series B financing to transform the treatment of kidney diseases
October 09, 2024 02:00 ET
|
Purespring Therapeutics
Purespring Therapeutics raises £80/$105 million in a Series B financing to transform the treatment of kidney diseases Oversubscribed financing led by Sofinnova Partners in collaboration with Gilde...
Purespring Therapeutics presents preclinical data at the 61st ERA Congress
May 24, 2024 10:57 ET
|
Purespring Therapeutics
Purespring Therapeutics presents preclinical data at the 61st ERA Congress Data establishes the potential of AAV gene therapy to deliver transgenes to the podocyte to replace defective genes or to...
Purespring appoints Fredrik Erlandsson as Chief Medical Officer and Peter Mulcahy as Chief People Officer
September 06, 2023 07:00 ET
|
Purespring Therapeutics
Purespring appoints Fredrik Erlandsson as Chief Medical Officer and Peter Mulcahy as Chief People Officer Appointments of Fredrik and Peter complete build-out of senior team London— 6 September...
Purespring Therapeutics appoints Sachin Kelkar as Chief Financial Officer following appointment of Julian Hanak as Chief Executive Officer
August 02, 2023 07:00 ET
|
Purespring Therapeutics
Senior leadership team strengthened as Purespring prepares kidney gene therapy programmes for clinical development London— 2 August 2023— Purespring Therapeutics, the pioneering gene therapy...
Purespring Therapeutics strengthens scientific leadership with the appointment of Alice Brown as Chief Scientific Officer
September 07, 2022 07:00 ET
|
Purespring Therapeutics
Purespring Therapeutics strengthens scientific leadership with the appointment of Alice Brown as Chief Scientific Officer London— 07 September 2022— Purespring Therapeutics, a pioneering gene therapy...
Purespring Therapeutics strengthens scientific leadership with the appointment of Alice Brown as Chief Scientific Officer
September 07, 2022 02:00 ET
|
Purespring Therapeutics
Purespring Therapeutics strengthens scientific leadership with the appointment of Alice Brown as Chief Scientific Officer London— 07 September 2022— Purespring Therapeutics, a pioneering gene therapy...
Purespring Therapeutics Expands Senior Team with Key Appointments
July 26, 2022 02:00 ET
|
Purespring Therapeutics
Purespring Therapeutics Expands Senior Team with Key Appointments Appointments include Dr Pille Harrison as VP of Clinical Development, Dr Aoife Waters as Medical Director, Nick Cetateanu as Head of...
Purespring Therapeutics and SwanBio Therapeutics announce licensing agreement for use of FunSel screening platform
July 18, 2022 07:00 ET
|
Purespring Therapeutics
Purespring Therapeutics and SwanBio Therapeutics announce licensing agreement for use of FunSel screening platform FunSel is Purespring’s proprietary in-vivo ‘gene search engine’, which allows...